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Abstract
Cerebral toxoplasmosis commonly affects patients
with advanced HIV immunodeficiency. Toxoplasmosis in
patients who are immunocompromised can be severe and
debilitating in patients with Central Nervous System (CNS)
involvement and the condition may be fatal. 
We report the case of a 40 years old man who was a
known case of HIV and presented with cerebral
toxoplasmosis. His Magnetic Resonance Imaging (MRI)
scan showed multiple ring enhancing lesions with extensive
surrounding oedema in supratentorial as well as
infratentorial region. Lesions were mainly located in the
periventricular region as well as at the grey-white matter
junction and showed enhancement in the periphery as well
as a tiny nodular enhancement in the centre. Patient was
started on Septran DS, empirically for toxoplasmosis and
steroids to reduce intracranial pressure. On follow up MRI
scan after 10 days there was a reduction in size, number and
enhancement of the masses with decrease in the
surrounding oedema. Patient was clinically stable, oriented
and his fever settled. He was discharged from hospital on
same medication and advised to continue regular follow-up.
Introduction
Toxoplasmosis, a common mass lesion in patients with
acquired immune deficiency syndrome (AIDS), is caused by
ubiquitous parasite, toxoplasma gondii. Human infection
usually occurs via the oral or trans-placental route.1 In adults,
most T.gondii infections are subclinical, but severe infections
can occur in patients who are immunocompromised (A.I.D.S,
Malignancy). AIDS associated toxoplasma encephalitis
results from reactivation of chronic latent infection in more
than 95% of patients.2 In patients with AIDS seropositive for
T.gondii, the risk for cerebral toxoplasmosis approaches
30%.3 Drug therapy does not eradicate T.gondii, and lifelong
therapy to avoid relapse is often necessary.1
Toxoplasmosis is the most common cause of focal
brain lesions in patients with AIDS and frequently localizes to
the basal ganglia, although other sites in the brain and spinal
cord may be affected, multiple foci are seen more often.1
Case Report
A 40 years old male patient was diagnosed as HIV
positive. Initially asymptomatic he had been bed bound for
last 2 months and unable to move his body, could not talk
and for last 4 days had fever and became disoriented and
stuperous. There was no history of seizures. On
examination, patient was vitally stable, Glasgow Coma
Scale (GCS) 7/15, neck stiffness was present, left sided
gaze, increased tone bilaterally, decreased bulk, reflexes
brisk and power 2/5 in all limbs was noted.
He underwent MRI brain with Gadolinium which
showed multiple ring enhancing lesions of variable sizes in
bilateral supra and infratentorial regions. Lesions were
mainly located in the periventricular region as well as at the
grey-white matter junction with extensive surrounding
oedema. These were causing mass effect with midline shift.
These lesions were enhancing in the periphery as well as a
tiny nodule in their centre. Based on these findings, diagnosis
of cerebral toxoplasmosis was suggested (Figure-1).
Further information obtained from biological and
immunological studies showed raised neutrophils count,
positive Toxo IgG antibodies, positive serum HIV and
raised C Reactive protein. CBC showed absolute
lymphocyte count 7.8%. CSF analysis and CD4 cell count
were not done. Patient's chest X-ray and Ultrasounds were
unremarkable. 
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Figure-1: (a) T1-Weighted Axial MR image showing multiple hypointense lesions
with perilesional edema. (b) T2-Weighted Axial MR image showing multiple
hyperintense lesions of varying sizes with marked surrounding vasogenic edema.
(c) Post contrast sagittal T1 image showing multiple lesions with enhancement in
the periphery and centre. (d) Post contrast coronal image showing multiple
supratentorial and infratentorial ring enhancing lesions with eccentric nodules: the
"target sign". (e) Diffusion weighted axial MR image showing multiple ring
enhancing lesions of varying sizes.
Brain biopsy was deferred because of financial
constraints and the patient was started on Septran DS
empirically for toxoplasmosis and steroids to reduce
intracranial pressure. He was also given Paracetamol,
Clarithromycin and rehydrated with intravenous fluids.
Follow-up MRI scan with Gadolinium performed
after ten days re-demonstrated multiple ring enhancing
lesions of various sizes in supra and infratentorial region.
These demonstrated mixed signals on T1, hyperintense on
T2-Weighted and Flair images. Post contrast images
showed peripheral and central enhancement. On
Susceptibility Weighted images the lesion showed
susceptibility effect. However on comparison with previous
MRI scan there was reduction in size, number and
enhancement of the masses as well as the surrounding
oedema. Lesions showed haemorrhagic component in them
(Figure-2).
Patient was clinically stable, oriented had started
taking orally and his fever settled. He was discharged from
hospital on same medication and advised to continue
regular follow-up.
Discussion
Diagnosis of toxoplasmosis is made clinically,
radiologically and by serology, histology or by molecular
methods. Toxoplasmosis associated with HIV infection
manifest primarily as toxoplasmic encephalitis and is a
frequent cause of focal CNS lesions. Characteristically,
toxoplasmic encephalitis presents with headache, altered
mental status and fever. Most common focal neurological
signs are motor weakness, speech disturbance. Patients can
present with seizures, cranial nerve abnormalities, visual
field defects, sensory disturbances, cerebellar dysfunction,
meningismus, movement disorders and neuropsychiatric
manifestations.4 Ocular and pulmonary diseases are the
most common presentations in patients with cerebral
toxoplasmosis.5 Toxoplasmosis rarely presents as a rapidly
fatal form of diffuse encephalitis. 
The most commonly used serologic tests to detect
the presence of anti-T gondii IgG and IgM. IgG antibodies
can be detected with the Sabin Feldman dye test (considered
to be the gold standard). CSF from patients with
toxoplasmic encephalitis may reveal mild pleocytic
mononuclear predominance and protein elevation.6
Polymerase chain reaction (PCR) based detection of
T.gondii DNA has sensitivity of 12-70 % and specificity of
100% in patients with toxoplasmic encephalitis.7
Toxoplasmosis can be diagnosed by isolation of T.gondii
from culture of body fluids (Blood, CSF, and
bronchoalveolar lavage fluids) or tissue biopsy. 
The cranial imaging features on CT and MRI are not
pathognomonic, but their distribution or appearance may
have predictive value. MRI is the best initial screening
procedure for CNS toxoplasmosis. CT scan reveals
multiple, bilateral, hypodense contrast enhancing focal
brain lesions in 70-80% of patients. These lesions tend to
involve basal ganglia and hemispheric corticomedullary
junction. Contrast enhancement often shows a ring like
pattern surrounding the lesion. Toxoplasmic encephalitis
may less frequently present with single lesion or with no
lesion on CT scan.8
MRI is more sensitive and is the preferred imaging
technique especially in patients with focal neurological
abnormalities. Typical radiological findings comprise of
bilateral, multiple, ring enhancing lesions over basal
ganglia and corticomedullary junctions of cerebral
hemisphere. In approximately 14% of cases, the lesions are
solitary. Haemorrhage may be seen occasionally, a finding
that can help differentiate toxoplasmosis from lymphoma
which typically does not bleed before treatment.
Occasionally a small eccentric nodule rests alongside an
enhancing ring; the "target sign" is highly suggestive of
toxoplasmosis. However, it is seen in less than 30% of
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Figure-2: (a): Follow up T1-Weighted axial MR Image shows multiple lesions with
mixed hypo and hyperintense signal and markedly reduced surrounding edema. (b) Post
contrast axial MR image shows multiple ring enhancing lesions, reduced in size,
number and enhancement with markedly reduced surrounding edema. (c) Coronal Flair
post contrast image shows multiple enhancing lesions in supratentorial and infratentorial
region. (d) Diffusion weighted MR Image showing multiple ring enhancing lesions.
cases. Surrounding oedema and mass effect are present in
varying degrees.8
The most important differential diagnosis is CNS
lymphoma. Features that favor the diagnosis of T.gondii
encephalitis over CNS lymphoma include: subcortical
lesions, more than three lesions, absence of ependymal or
leptomeningeal involvement, marked perilesional oedema,
absence of hyper attenuation on non enhanced CT scans or
slender uniform ring enhancing foci.9 Diffusion weighted
imaging has been suggested to help differentiate between
the two diseases, as lymphoma typically has restricted
diffusion. Unfortunately, toxoplasmosis demonstrates a
wide range of diffusion characteristics which can overlap
with those of lymphoma.8 Increased uptake in SPECT or
PET can enhance the specificity for the detection of CNS
lymphoma.
Brain biopsy showing tachyzoites or cyst provides a
definitive diagnosis for toxoplasmosis encephalitis.
Conservative approach is particularly helpful when the
lesion is surgically inaccessible. Combination of
Pyrimethamine /Sulfadiazine and folinic acid is considered
the standard regime for the treatment of toxoplasmosis
encephalitis.6 Short course of corticosteroids can be used in
toxoplasmosis encephalitis patients with significant cerebral
edema and elevated intracranial pressure. Toxoplasmosis
will reoccur if therapy is discontinued.8
Empirical treatment for T.gondii should be started on
patients with multiple ring enhancing lesions on MRI,
positive serology for Toxoplasma IgG, and absolute CD4
count less than 200 cells/mm3.4
If an empiric course of treatment is begun for
toxoplasmosis without biopsy, then a repeat cranial study is
recommended. If CT or MRI findings are unchanged, then
biopsy is indicated. Both CT and MRI may be used for
follow up after treatment. In our case the appearance of the
lesions was very characteristic as there were a number of
"target Lesions" in the brain. Also the distribution of the
lesions was also typical in our case. We used MRI to follow
up the case to see the response.
Primary prophylaxis should be considered in HIV
patients with CD4 cell counts less than 200 and positive
Toxoplasma IgG titers. Prophylaxis can be discontinued
when the patients CD4 cell count has returned to over 200
for atleast 6 months.4
HIV infected persons should be tested for baseline
IgG antibodies to Toxoplasma to detect latent infection with
T. gondii. All HIV infected persons should be councelled
regarding exposure to toxoplasmic infection. (a) Avoid
eating raw or undercooked meat. (b) Wash hands after
contact with raw meat. (c) Wash fruits and vegetables well.
(d) Avoid handling cat's litter.10
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